Chlorhexidine Gluconate (CHG) Wipes Market Report 2025

This Chlorhexidine Gluconate (CHG) Wipes market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The chlorhexidine gluconate (CHG) wipes market size has grown strongly in recent years. It will grow from $49.92 billion in 2024 to $52.53 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to healthcare-associated infections (hais) concerns, surgical site infections (ssis) prevention, regulatory endorsement, increased hospital admissions, rise in chronic diseases.

The chlorhexidine gluconate (CHG) wipes market size is expected to see strong growth in the next few years. It will grow to $65.7 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to pandemic-driven hygiene measures, growing elderly population, global expansion of healthcare facilities, consumer awareness and demand, government initiatives for infection control. Major trends in the forecast period include environmentally friendly formulations, enhanced packaging designs, innovation in wipe textures, telemedicine and remote care, focus on otc and retail market.

The rise in surgical procedures is anticipated to drive the growth of the chlorhexidine gluconate (CHG) wipes market in the future. A surgical procedure involves making an incision and using instruments to treat or repair a disease in a living organism. CHG wipes are utilized in a wide range of surgical procedures to eliminate potentially harmful microbes on the skin and inhibit the proliferation of additional microbes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures nearly reached 35 million in 2023, with the total number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Thus, the growth in surgical procedures is propelling the chlorhexidine gluconate (CHG) wipes market forward.

The growth of the chlorhexidine gluconate (CHG) wipes market is anticipated to be propelled by the mounting incidence of healthcare-associated infections (HAIs). Healthcare-associated infections (HAIs) denote infections contracted by individuals during their healthcare treatment within hospital, clinic, or similar settings. Chlorhexidine gluconate (CHG) wipes play a pivotal role in mitigating the risk of healthcare-associated infections (HAIs) by offering effective antiseptic skin preparation in medical environments. For example, a report published by the World Health Organization (WHO) in May 2022 highlighted alarming statistics, more than 24% of patients afflicted by healthcare-associated sepsis and 52.3% of those treated in intensive care units succumb to the condition annually. The risk of mortality significantly amplifies when infections exhibit resistance to antimicrobial treatments. In acute-care hospitals, an estimated 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries are expected to acquire at least one healthcare-associated infection (HAI) during their hospital stay. Hence, the surge in healthcare-associated infections (HAIs) is anticipated to be a driving force behind the chlorhexidine gluconate (CHG) wipes market's growth trajectory.

Product innovation has become a significant trend gaining traction in the chlorhexidine gluconate (CHG) wipes market. Key players in the market are focusing on developing innovative products to reinforce their market position. For instance, in August 2024, Irrimax Corporation, a US-based manufacturing company, launched new IRRISEPT kits, marking the second phase of its innovation pipeline aimed at improving wound irrigation solutions. The newly launched IRRISEPT Accessory Kit and IRRISEPT Wound Solution Kit are designed to enhance the original IRRISEPT Antimicrobial Wound Lavage product, providing clinicians with increased flexibility in their applications, including compatibility with powered irrigation devices. This initiative addresses customer feedback regarding the demand for effective irrigation solutions in minimally invasive procedures. Irrimax's commitment to reducing infections and healthcare costs while enhancing patient outcomes remains central to its mission as it continues to broaden its product offerings in the healthcare market.

Significant companies operating in the chlorhexidine gluconate (CHG) wipes market are intensifying their focus on developing innovative products, such as antiseptic solutions, to expand their product portfolios and cater to the escalating demand for effective and adaptable antiseptic solutions. Notably, in June 2023, HR Pharmaceuticals, Inc. unveiled CliniClean Chlorhexidine Gluconate (CHG) 4%, an antiseptic solution tailored to provide comprehensive skin protection against a diverse range of microorganisms, effectively reducing the risks associated with healthcare-associated and surgical site infections. This versatile antiseptic/antimicrobial solution is adeptly designed for various applications including patient pre-operative preparation, surgical hand scrubs, healthcare personnel handwashing, as well as general skin and wound cleansing. The clinical efficacy of CliniClean is evident in its ability to substantially diminish skin bacteria through repeated use, ensuring prolonged germ-fighting efficacy even after application.

In September 2022, Schülke & Mayr GmbH, a Germany-based healthcare company, successfully acquired Vesismin Health for an undisclosed amount. This strategic acquisition served to enhance Schülke & Mayr's product portfolio in infection prevention and hygiene solutions. Vesismin Health, based in Spain, is a manufacturer specializing in infection prevention and hospital disinfection products, including Chlorhexidine Gluconate (CHG) wipes and Chlorhexidine Antiseptic.

Chlorhexidine gluconate (CHG) wipes are disposable cloths containing chlorhexidine gluconate, an antibacterial agent designed to eliminate bacteria on the skin. These wipes are primarily employed to sanitize the skin before surgical procedures.

There are two main types of CHG wipes such as chlorhexidine gluconate (CHG) bath wipes and chlorhexidine gluconate (CHG) alcohol-based wipes. CHG bath wipes are disposable antiseptic cloths that facilitate bathing for hospital patients without the need for rinsing. They are utilized to cleanse the skin and prevent infections. Applications for these wipes include addressing surgical site infections, central line-associated bloodstream infections, catheter-associated urinary tract infections, and other related conditions. Distribution channels for CHG wipes encompass pharmacies, supermarkets, specialty stores, and direct sales channels, catering to a wide range of healthcare facilities such as hospitals, clinics, ambulatory surgical centers, among others.

The chlorhexidine gluconate (CHG) wipes research report is one of a series of new reports that provides chlorhexidine gluconate (CHG) wipes market statistics, including the chlorhexidine gluconate (CHG) wipes industry's global market size, regional shares, competitors with chlorhexidine gluconate (CHG) wipes market share, detailed chlorhexidine gluconate (CHG) wipes market segments, market trends and opportunities, and any further data you may need to thrive in the chlorhexidine gluconate (CHG) wipes industry. This chlorhexidine gluconate (CHG) wipes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Major companies operating in the chlorhexidine gluconate (CHG) wipes market include Cardinal Health Inc., 3M Co, Johnson & Johnson MedTech, McKesson Medical-Surgical Inc., Medline Industries Inc., Becton Dickinson and Company, Stryker Corporation, Ecolab Inc., Smith & Nephew Plc., Ethicon Inc., Coloplast AS, Purdue Products L.P, Owens & Minor Inc., Pal International, Molnlycke Health Care AB, Halyard Health Inc., Nice-Pak Products Inc., Sage Products LLC, GAMA Healthcare Ltd., Dynarex-Corporation, AvaCare Medical LLC, PDI Ltd., Lernapharm Inc., Carenow Medical Pvt. Ltd., Clinicept Healthcare Ltd.

North America was the largest region in the chlorhexidine gluconate (CHG) wipes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chlorhexidine gluconate (chg) wipes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chlorhexidine gluconate (chg) wipes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chlorhexidine gluconate (CHG) wipes market consists of sales of skin antiseptic wipes, pre-surgery wash sponges, and surgical skin disinfectants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.